Det Ansinn is the CEO of Neuralert Technologies, leading the company’s mission to revolutionize stroke detection with real-time, continuous monitoring technology. Det is known for his expertise in medical devices, AI, and healthcare technology. As a serial entrepreneur, he has four prior exits. With extensive experience developing FDA approved mobile and wearable devices, he previously served as Neuralert's CTO before becoming CEO in August 2024.

Dr. Steven Messé is Professor, Dept of Neurology, Univ of Penn., and Director of the Center for Neuro-Cardio Protection. He received the Michael S. Pessin Stroke Leadership Award from American Academy of Neurology, is a Member of the American Heart Association (AHA) Get With The Guidelines Steering Committee, Chair of the AHA Stroke Systems of Care Workgroup and Member of the AHA International Stroke Conference Program Committee.

Dr. Weimer is an expert in Computer Science and Signal processing and most recently received the Career Award from the National Science Foundation. He has received multiple best-paper awards including the International Conference on Cyber-Physical Systems for work on his Parameter-Invariant detection algorithm, the detection core of Neuralert.

Brian Kieser is the CFO of Neuralert Technologies, bringing over 30 years of expertise in financial strategy, mergers and acquisitions, and operational turnarounds. He has successfully led numerous companies through high-impact initiatives, including securing funding, managing financial restructurings, and facilitating strategic exits.

40+ years in MedTech, Experienced CEO, Board Chair, Independent Director of public and private life science companies

25+ years in MedTech Experience spanning Fortune 500 and startups Senior leadership through mergers/acquisitions

Chair of the Cardiovascular Service Line, Baylor Scott & White
Health and Chairman of the Board, Baylor Scott & White Research Institute. Expert in Stroke in Cardiac Surgery and Intervention